XOMA Corp Purchase Agreements
13 Contracts & Agreements
- Amendment No. 1 to Royalty Purchase Agreement entered into as of March 4, 2024 by and between Viracta (Filed With SEC on May 9, 2024)
- Payment Interest Purchase Agreement by and between (Filed With SEC on May 9, 2024)
- Royalty Purchase Agreement, dated as of June 21, 2023, by and between XOMA (US) LLC and LadRx Corporation (Filed With SEC on August 8, 2023)
- Payment Interest Purchase Agreement, dated March 29, 2023, by and between Aptevo Therapeutics Inc. and XOMA (US) LLC (Filed With SEC on May 9, 2023)
- Amendment and Restatement, dated February 2, 2017, to the Asset Purchase Agreement, dated November 4, 2015, and License Agreement, dated March 23, 2016, between XOMA Corporation... (Filed With SEC on November 3, 2022)
- Commercial Payment Purchase Agreement, dated October 6, 2021, by and among XOMA (US) LLC and Affitech Research AS (Filed With SEC on March 8, 2022)
- Royalty Purchase Agreement, dated July 14, 2021, by and among XOMA (US) LLC and Kuros Royalty Fund (US) LLC (Filed With SEC on November 4, 2021)
- Royalty Purchase Agreement dated March 22, 2021 between XOMA (US) LLC and Viracta Therapeutics, Inc (Filed With SEC on May 6, 2021)
- Royalty Purchase Agreement dated September 26, 2019 between XOMA (US) LLC and Palobiofarma, S.L (Filed With SEC on November 5, 2019)
- Royalty Purchase Agreement dated April 7, 2019, between XOMA (US) LLC and Aronora, Inc (Filed With SEC on August 6, 2019)
- Royalty Purchase Agreement dated September 20, 2018, between XOMA Corporation and Agenus Inc (Filed With SEC on November 7, 2018)
- ASSET PURCHASE AGREEMENT by and among AGENUS WEST, LLC and AGENUS INC. (solely with respect to its obligations under Sections4.4, Section 8.3, and Article7) and XOMA CORPORATION... (Filed With SEC on March 9, 2016)
- XOMA LTD. WARRANTTO PURCHASE COMMON SHARES (Filed With SEC on February 2, 2010)
